ID   PLPP4_HUMAN             Reviewed;         271 AA.
AC   Q5VZY2; A2RU82; Q08EQ2; Q0IIP2; Q495B4; Q5VZY1;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 2.
DT   15-MAR-2017, entry version 106.
DE   RecName: Full=Phospholipid phosphatase 4 {ECO:0000312|HGNC:HGNC:23531};
DE            EC=3.1.3.4;
DE   AltName: Full=Phosphatidic acid phosphatase type 2 domain-containing protein 1A;
GN   Name=PLPP4 {ECO:0000312|HGNC:HGNC:23531};
GN   Synonyms=DPPL2, PPAPDC1, PPAPDC1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, TISSUE SPECIFICITY,
RP   ENZYME REGULATION, CATALYTIC ACTIVITY, REGION, MUTAGENESIS OF ARG-109;
RP   HIS-146 AND HIS-202, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17590538; DOI=10.1016/j.gene.2007.05.009;
RA   Takeuchi M., Harigai M., Momohara S., Ball E., Abe J., Furuichi K.,
RA   Kamatani N.;
RT   "Cloning and characterization of DPPL1 and DPPL2, representatives of a
RT   novel type of mammalian phosphatidate phosphatase.";
RL   Gene 399:174-180(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Displays magnesium-independent phosphatidate phosphatase
CC       activity in vitro. Catalyzes the conversion of phosphatidic acid
CC       to diacylglycerol. {ECO:0000269|PubMed:17590538}.
CC   -!- CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a
CC       1,2-diacyl-sn-glycerol + phosphate. {ECO:0000269|PubMed:17590538}.
CC   -!- ENZYME REGULATION: Inhibited by N-ethylmaleimide.
CC       {ECO:0000269|PubMed:17590538}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=104 uM for diacylglycerol pyrophosphate
CC         {ECO:0000269|PubMed:17590538};
CC         KM=506 uM for phosphatidate {ECO:0000269|PubMed:17590538};
CC         KM=580 uM for lysophosphatidate {ECO:0000269|PubMed:17590538};
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-10485931, EBI-10485931;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q5VZY2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5VZY2-2; Sequence=VSP_025238;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q5VZY2-3; Sequence=VSP_025237;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q5VZY2-4; Sequence=VSP_025239, VSP_025240;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed mainly to the brain, kidney and
CC       testis, and to a lesser extent the bone marrow, thymus, prostate,
CC       liver and uterus. {ECO:0000269|PubMed:17590538}.
CC   -!- SIMILARITY: Belongs to the PA-phosphatase related phosphoesterase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH70333.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BD418666; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL157782; CAH70332.1; ALT_TERM; Genomic_DNA.
DR   EMBL; AC073587; CAH70332.1; JOINED; Genomic_DNA.
DR   EMBL; AC023282; CAH70332.1; JOINED; Genomic_DNA.
DR   EMBL; AL157782; CAH70333.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC023282; CAH70333.1; JOINED; Genomic_DNA.
DR   EMBL; AC073587; CAH70333.1; JOINED; Genomic_DNA.
DR   EMBL; BC101267; AAI01268.1; -; mRNA.
DR   EMBL; BC101268; AAI01269.1; -; mRNA.
DR   EMBL; BC101269; AAI01270.1; -; mRNA.
DR   EMBL; BC122535; AAI22536.1; -; mRNA.
DR   EMBL; BC132787; AAI32788.1; -; mRNA.
DR   CCDS; CCDS41573.1; -. [Q5VZY2-1]
DR   RefSeq; NP_001025230.1; NM_001030059.2. [Q5VZY2-1]
DR   RefSeq; NP_001305095.1; NM_001318166.1.
DR   RefSeq; NP_001305096.1; NM_001318167.1. [Q5VZY2-2]
DR   RefSeq; NP_001305097.1; NM_001318168.1.
DR   RefSeq; NP_001305098.1; NM_001318169.1. [Q5VZY2-4]
DR   UniGene; Hs.40479; -.
DR   ProteinModelPortal; Q5VZY2; -.
DR   SMR; Q5VZY2; -.
DR   BioGrid; 128189; 1.
DR   IntAct; Q5VZY2; 10.
DR   STRING; 9606.ENSP00000381302; -.
DR   SwissLipids; SLP:000000605; -.
DR   DEPOD; Q5VZY2; -.
DR   iPTMnet; Q5VZY2; -.
DR   PhosphoSitePlus; Q5VZY2; -.
DR   BioMuta; PPAPDC1A; -.
DR   DMDM; 147721098; -.
DR   PaxDb; Q5VZY2; -.
DR   PeptideAtlas; Q5VZY2; -.
DR   PRIDE; Q5VZY2; -.
DR   Ensembl; ENST00000398250; ENSP00000381302; ENSG00000203805. [Q5VZY2-1]
DR   GeneID; 196051; -.
DR   KEGG; hsa:196051; -.
DR   UCSC; uc001lev.1; human. [Q5VZY2-1]
DR   CTD; 196051; -.
DR   DisGeNET; 196051; -.
DR   GeneCards; PLPP4; -.
DR   HGNC; HGNC:23531; PLPP4.
DR   HPA; HPA045188; -.
DR   neXtProt; NX_Q5VZY2; -.
DR   OpenTargets; ENSG00000203805; -.
DR   PharmGKB; PA134907381; -.
DR   eggNOG; KOG3030; Eukaryota.
DR   eggNOG; COG0671; LUCA.
DR   GeneTree; ENSGT00510000046723; -.
DR   HOGENOM; HOG000215098; -.
DR   HOVERGEN; HBG056764; -.
DR   InParanoid; Q5VZY2; -.
DR   OMA; KEEMPTA; -.
DR   OrthoDB; EOG091G0O0I; -.
DR   PhylomeDB; Q5VZY2; -.
DR   TreeFam; TF323722; -.
DR   BioCyc; MetaCyc:G66-31698-MONOMER; -.
DR   BRENDA; 3.1.3.4; 2681.
DR   BRENDA; 3.1.3.81; 2681.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   ChiTaRS; PPAPDC1A; human.
DR   GeneWiki; PPAPDC1A; -.
DR   GenomeRNAi; 196051; -.
DR   PRO; PR:Q5VZY2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000203805; -.
DR   CleanEx; HS_PPAPDC1A; -.
DR   ExpressionAtlas; Q5VZY2; baseline and differential.
DR   Genevisible; Q5VZY2; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0046839; P:phospholipid dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 1.20.144.10; -; 1.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   InterPro; IPR028668; PLPP4.
DR   PANTHER; PTHR10165:SF121; PTHR10165:SF121; 1.
DR   Pfam; PF01569; PAP2; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; SSF48317; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Hydrolase; Membrane;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    271       Phospholipid phosphatase 4.
FT                                /FTId=PRO_0000286943.
FT   TRANSMEM      4     24       Helical. {ECO:0000255}.
FT   TRANSMEM     49     69       Helical. {ECO:0000255}.
FT   TRANSMEM     84    104       Helical. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TRANSMEM    179    199       Helical. {ECO:0000255}.
FT   TRANSMEM    202    222       Helical. {ECO:0000255}.
FT   REGION      102    110       Phosphatase sequence motif I.
FT   REGION      143    146       Phosphatase sequence motif II.
FT   REGION      195    205       Phosphatase sequence motif III.
FT   VAR_SEQ       1    189       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025237.
FT   VAR_SEQ      56     96       AISFLTPLAVICVVKIIRRTDKTEIKEAFLAVSLALALNGV
FT                                -> IPLWVESSASFLHTFATDSTILLWPTQLAINPTLVCES
FT                                QPH (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025239.
FT   VAR_SEQ      86    149       AVSLALALNGVCTNTIKLIVGRPRPDFFYRCFPDGVMNSEM
FT                                HCTGDPDLVSEGRKSFPSIHSSF -> V (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025238.
FT   VAR_SEQ      97    271       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025240.
FT   MUTAGEN     109    109       R->A: Loss of phosphatase activity; when
FT                                associated with A-146 and with A-202.
FT                                {ECO:0000269|PubMed:17590538}.
FT   MUTAGEN     146    146       H->A: Loss of phosphatase activity; when
FT                                associated with A-109 and with A-202.
FT                                {ECO:0000269|PubMed:17590538}.
FT   MUTAGEN     202    202       H->A: Loss of phosphatase activity; when
FT                                associated with A-109 and with A-146.
FT                                {ECO:0000269|PubMed:17590538}.
SQ   SEQUENCE   271 AA;  30395 MW;  C534549E44DDB9A1 CRC64;
     MRELAIEIGV RALLFGVFVF TEFLDPFQRV IQPEEIWLYK NPLVQSDNIP TRLMFAISFL
     TPLAVICVVK IIRRTDKTEI KEAFLAVSLA LALNGVCTNT IKLIVGRPRP DFFYRCFPDG
     VMNSEMHCTG DPDLVSEGRK SFPSIHSSFA FSGLGFTTFY LAGKLHCFTE SGRGKSWRLC
     AAILPLYCAM MIALSRMCDY KHHWQDSFVG GVIGLIFAYI CYRQHYPPLA NTACHKPYVS
     LRVPASLKKE ERPTADSAPS LPLEGITEGP V
//
